Three-Dimensional Stem Cell Spheres for Arthritis Cartilage Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis primarily focus on pain management and cannot prevent further degeneration of joints, leading to significant disability and the need for surgical interventions like total knee replacement.
Innovation Solution
A method involving the administration of a pharmaceutical composition comprising an effective amount of a stem cell preparation, specifically three-dimensional stem cell spheres, which are prepared by seeding primary human adipose-derived stem cells on a scaffold and undergoing static and dynamic cultivations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If current treatments for osteoarthritis (pain management, NSAIDs, corticosteroids, hyaluronic acid) are used, then pain relief is achieved, but cartilage degradation continues and joint function deteriorates
Solution Approach 1:
The patent applies preliminary action by using stem cell therapy to regenerate cartilage tissue before severe joint destruction occurs. The stem cells are introduced to prevent further degeneration and promote cartilage repair, addressing the root cause rather than just managing symptoms. This proactive approach aims to preserve joint function and delay or prevent the need for surgical intervention.
Solution Approach 2:
The patent employs self-service by utilizing the body's own stem cells (autologous stem cells) to repair damaged cartilage. The stem cells are harvested from the patient's own adipose tissue, expanded in culture, and re-injected into the affected joint. This approach leverages the patient's inherent regenerative capacity to restore cartilage tissue, reducing reliance on external substances that may have side effects.
2Ease of operation
If surgical operations like total knee replacement are performed, then joint function is restored, but patient acceptance is low and it does not prevent further degeneration in other joints
Solution Approach 1:
The patent uses autologous stem cells harvested from the patient's own adipose tissue to regenerate cartilage, eliminating the need for donor cells or synthetic materials. This self-service approach increases patient acceptance by avoiding immun rejection and reducing the need for invasive surgery. The minimally invasive nature of the stem cell injection procedure compared to total knee replacement makes it more acceptable to patients.
Solution Approach 2:
The patent changes the treatment parameter from mechanical replacement of the joint (surgery) to biological regeneration of cartilage tissue. By shifting from a mechanical solution (prosthesis) to a biological solution (stem cell therapy), the treatment addresses the underlying degenerative process and can be applied to multiple joints, preventing progression rather than just replacing damaged structures.
3Speed
If joint replacement surgery is performed, then mobility is improved, but it cannot prevent arthritis in other joints and has significant recovery time
Solution Approach 1:
The patent applies universality by using the same stem cell therapy approach that can treat multiple joints and prevent arthritis progression throughout the body. Unlike joint replacement which addresses only one joint at a time, stem cell therapy can be administered to multiple affected joints with the same treatment protocol, providing a universal solution that prevents further degeneration systemically rather than locally.
Solution Approach 2:
The patent implements preliminary action by introducing stem cells to regenerate cartilage and prevent arthritis progression before severe damage occurs in other joints. This preventive approach addresses the underlying degenerative process early, potentially preventing the need for multiple future surgeries and reducing overall recovery time across all affected joints.
Data Source
AI summary
The present disclosure provides a method for treating arthritis by using a stem cell preparation. The stem cell preparation of the present disclosure can effectively delay cartilage degeneration caused by arthritis, and it is confirmed by whole blood analysis and blood biochemical analysis that the stem cell preparation in the form of three-dimensional stem cell spheres provides a safe treatment for arthritis. The present disclosure also provides a method for preparing the stem cell preparation.